Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Eur Urol. 2019 Oct 21;77(2):170–177. doi: 10.1016/j.eururo.2019.08.020

Fig. 2 –

Fig. 2 –

Factors influencing physician decisions to assign an androgen receptor signaling inhibitor (ARSI) or taxane. (A) Factors influencing physician decision to assign ARSI or taxane. Arrows indicate the relative odds for taxane use predicted by the model given the condition. (B) Distribution of patients by their propensity scores and actual therapy assigned, colored by AR-V7 status. Patients with a wide range of propensity to receive either an ARSI or a taxane could test positive for AR-V7.

LLN = lower limit of normal; Tx = treatment; ULN = upper limit of normal.